Clin2
NCT04588402Possibly a fitRecruiting

Tests whether HPV vaccination prevents cervical HPV infection in young women

Cervical Cancer

Part of Cancer, Women’s health & pregnancy clinical trials.

This study looks at whether HPV vaccination lowers the chance of getting HPV in the cervix. It will collect cervical samples and ask questions to see how vaccination affects infection in women in Sikkim, India.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,500 people
Ages
18 years to 22 years
Study type
Observational

Who can take part

  • You are a woman age 18 to 22
  • You live in Sikkim and are married
  • You can give written consent to join
  • You are able to cooperate with cervical sample collection and answer questions
  • You have not had a hysterectomy (surgery removing the uterus)
  • You are not already vaccinated as part of a research project

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06681636Not yet recruiting· Phase 2
HPV vaccine immune study in Vietnamese women

This trial tests how well the HPV vaccine triggers immune memory in women who may have been exposed to HPV. It could help protect against future HPV infections and related cancers.

Parkville, Victoria
NCT04422366Recruiting· Phase 3
9-valent HPV vaccine study for healthy Chinese women

This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.

Liuzhou, Guangxi
NCT04910802Recruiting· Phase 4
HPV vaccine with routine HPV screening for ages 22–26

This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.

Stockholm
NCT07077980Not yet recruiting
HPV vaccine trial for cervical cancer patients

This trial is testing a new vaccine designed to help your immune system fight cervical cancer caused by HPV types 16 or 18. It is for women who are receiving standard treatment like surgery, chemotherapy, or radiation.

Hefei, Anhui
NCT07209917Recruiting
Cervical cancer prevention for women with HIV and HPV

This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.

Bangalore, Karnataka
NCT07593066Not yet recruiting
Cervical cancer screening study for women

This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.

Coyhaique, Aysén

Hear when a new Cervical Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.